Biotechnological production of sphingoid bases and their applications

[1]  C. Pozzilli,et al.  Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod , 2013, Therapeutics and clinical risk management.

[2]  H. Riezman,et al.  Sphingolipid signaling in yeast: potential implications for understanding disease. , 2013, Frontiers in bioscience.

[3]  E. Boles,et al.  Production of tetraacetyl phytosphingosine (TAPS) in Wickerhamomyces ciferrii is catalyzed by acetyltransferases Sli1p and Atf2p , 2013, Applied Microbiology and Biotechnology.

[4]  A. Goesmann,et al.  Draft Genome Sequence of Wickerhamomyces ciferrii NRRL Y-1031 F-60-10 , 2012, Eukaryotic Cell.

[5]  G. Menon,et al.  International Journal of Pharmaceutics , 2012 .

[6]  E. Boles,et al.  Metabolic engineering of the non-conventional yeast Pichia ciferrii for production of rare sphingoid bases. , 2012, Metabolic engineering.

[7]  E. Boles,et al.  High-level production of tetraacetyl phytosphingosine (TAPS) by combined genetic engineering of sphingoid base biosynthesis and L-serine availability in the non-conventional yeast Pichia ciferrii. , 2012, Metabolic engineering.

[8]  Y. Hannun,et al.  Sphingoid Bases and the Serine Catabolic Enzyme CHA1 Define a Novel Feedforward/Feedback Mechanism in the Response to Serine Availability* , 2012, The Journal of Biological Chemistry.

[9]  L. Kircik,et al.  Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. , 2011, The Journal of clinical and aesthetic dermatology.

[10]  H. Ikushiro,et al.  Mechanistic enzymology of serine palmitoyltransferase. , 2011, Biochimica et biophysica acta.

[11]  S. Castillón,et al.  Recent Advances in the Synthesis of Sphingosine and Phytosphingosine, Molecules of Biological Significance , 2010 .

[12]  Volker Brinkmann,et al.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis , 2010, Nature Reviews Drug Discovery.

[13]  R. Schneiter,et al.  Orm1 and Orm2 are conserved endoplasmic reticulum membrane proteins regulating lipid homeostasis and protein quality control , 2010, Proceedings of the National Academy of Sciences.

[14]  J. Na,et al.  A new moisturizer containing physiologic lipid granules alleviates atopic dermatitis , 2010, The Journal of dermatological treatment.

[15]  Christer S. Ejsing,et al.  Orm family proteins mediate sphingolipid homeostasis , 2010, Nature.

[16]  R. C. Dickson.  Roles for sphingolipids in Saccharomyces cerevisiae. , 2010, Advances in experimental medicine and biology.

[17]  G. Francis,et al.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis , 2010, Nature Reviews Drug Discovery.

[18]  E. Boles,et al.  Knockout of the DNA ligase IV homolog gene in the sphingoid base producing yeast Pichia ciferrii significantly increases gene targeting efficiency , 2009, Current Genetics.

[19]  Rainer Höfer,et al.  Sustainable Solutions for Modern Economies , 2009 .

[20]  J. Mandl,et al.  Novel sphingolipid derivatives promote keratinocyte differentiation , 2008, Experimental dermatology.

[21]  S. van Calenbergh,et al.  Fungicidal activity of truncated analogues of dihydrosphingosine. , 2008, Bioorganic & medicinal chemistry letters.

[22]  Takashi Kitahara,et al.  Characterization of overall ceramide species in human stratum corneums⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of two figures and two tables. Published, JLR Papers in Press, March 23, 2008. , 2008, Journal of Lipid Research.

[23]  A V Rawlings,et al.  Salicyloyl‐phytosphingosine: a novel agent for the repair of photoaged skin , 2007, International journal of cosmetic science.

[24]  H. Korting,et al.  Anti‐microbial and ‐inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris , 2007, International journal of cosmetic science.

[25]  A. Rawlings,et al.  Acne and its therapy , 2007 .

[26]  Y. Hannun,et al.  Selective Substrate Supply in the Regulation of Yeast de Novo Sphingolipid Synthesis* , 2007, Journal of Biological Chemistry.

[27]  M. Farwick,et al.  The Effect of Sphingolipids as a New Therapeutic Option for Acne Treatment , 2007 .

[28]  W. Holleran,et al.  Epidermal sphingolipids: Metabolism, function, and roles in skin disorders , 2006, FEBS letters.

[29]  R. Blumenthal,et al.  The clinical potential of sphingolipid-based therapeutics , 2006, Cellular and Molecular Life Sciences CMLS.

[30]  J. Bouwstra,et al.  Lipid mixtures prepared with well-defined synthetic ceramides closely mimic the unique stratum corneum lipid phase behavior Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500221-JLR200 , 2005, Journal of Lipid Research.

[31]  샤퍼 스테펜.  Microbial strains producing sphingoid bases or derivatives thereof , 2005 .

[32]  クネルケル，ハンス−ヨアヒム,et al.  Sphingolipid derived pharmaceutical compositions , 2005 .

[33]  Eoin Fahy,et al.  A comprehensive classification system for lipids11 The evaluation of this manuscript was handled by the former Editor-in-Chief Trudy Forte. Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.E400004-JLR200 , 2005, Journal of Lipid Research.

[34]  S. Udaka,et al.  Studies on the amino acid fermentation. Part 1. Production of L-glutamic acid by various microorganisms. , 2004, The Journal of general and applied microbiology.

[35]  Y. Hannun,et al.  The complex life of simple sphingolipids , 2004, EMBO reports.

[36]  J. Sohn,et al.  Cloning and functional characterization of the SUR2/SYR2 gene encoding sphinganine hydroxylase in Pichia ciferrii , 2004, Yeast.

[37]  W. Curatolo.  The Lipoidal Permeability Barriers of the Skin and Alimentary Tract , 1987, Pharmaceutical Research.

[38]  K. Tsubota,et al.  Treatment of atopic blepharitis by controlling eyelid skin water retention ability with ceramide gel application , 2003, The British journal of ophthalmology.

[39]  H. Riezman,et al.  Lcb4p Is a Key Regulator of Ceramide Synthesis from Exogenous Long Chain Sphingoid Base in Saccharomyces cerevisiae* , 2003, The Journal of Biological Chemistry.

[40]  J. Sohn,et al.  Integrative Transformation System for the Metabolic Engineering of the Sphingoid Base-Producing Yeast Pichia ciferrii , 2003, Applied and Environmental Microbiology.

[41]  E. Kimura,et al.  Metabolic engineering of glutamate production. , 2003, Advances in biochemical engineering/biotechnology.

[42]  A. Kihara,et al.  Identification and Characterization of aSaccharomyces cerevisiae Gene, RSB1, Involved in Sphingoid Long-chain Base Release* , 2002, The Journal of Biological Chemistry.

[43]  Y. Hannun,et al.  Cystic Fibrosis Transmembrane Regulator Regulates Uptake of Sphingoid Base Phosphates and Lysophosphatidic Acid , 2001, The Journal of Biological Chemistry.

[44]  S. Bonhoeffer,et al.  Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.

[45]  Scott,et al.  Dry skin, moisturization and corneodesmolysis , 2000, International journal of cosmetic science.

[46]  J. Takemoto,et al.  Syringomycin Action Gene SYR2 Is Essential for Sphingolipid 4-Hydroxylation in Saccharomyces cerevisiae * , 1998, The Journal of Biological Chemistry.

[47]  S. Garrett,et al.  The BST1 Gene of Saccharomyces cerevisiaeIs the Sphingosine-1-phosphate Lyase* , 1997, The Journal of Biological Chemistry.

[48]  P. Cliften,et al.  SYR2, a gene necessary for syringomycin growth inhibition of Saccharomyces cerevisiae. , 1996, Microbiology.

[49]  H. Shinefield,et al.  Topical sphingolipids in antisepsis and antifungal therapy , 1995, Clinical and experimental dermatology.

[50]  M. E. Stewart,et al.  6-Hydroxy-4-sphingenine in human epidermal ceramides. , 1994, Journal of lipid research.

[51]  H. Shinefield,et al.  Antimicrobial activity of sphingosines. , 1992, The Journal of investigative dermatology.

[52]  M. Kerscher,et al.  Skin ceramides : Structure and function , 1991 .

[53]  B Sonnleitner,et al.  Growth of Saccharomyces cerevisiae is controlled by its limited respiratory capacity: Formulation and verification of a hypothesis , 1986, Biotechnology and bioengineering.

[54]  Y. Barenholz,et al.  The metabolic basis for the accumulation of acetylated sphingosine bases in the yeast Hansenula ciferri , 1971 .

[55]  Karlsson Ka.  Studies on sphingosines. II. The chemical structure of phytosphingosine of human origin and a note on the lipid composition of the yeast Hansenula ciferrii. , 1966 .

[56]  K. Karlsson.  Studies on sphingosines. II. The chemical structure of phytosphingosine of human origin and a note on the lipid composition of the yeast Hansenula ciferrii. , 1966, Acta Chemica Scandinavica.

[57]  L. J. Wickerham,et al.  PHYLOGENY AND BIOCHEMISTRY OF THE GENUS HANSENULA , 1962, Bacteriological reviews.

[58]  L. J. Wickerham,et al.  Formation of Extracellular Sphingolipids by Microorganisms: IV. Pilot-Plant Production of Tetraacetylphytosphingosine by Hansenula ciferrii. , 1962, Applied microbiology.

[59]  L. J. Wickerham,et al.  FORMATION OF EXTRACELLULAR SPHINGOLIPIDES BY MICROORGANISMS , 1960, Journal of bacteriology.

[60]  L. J. Wickerham,et al.  Formation of Extracellular Sphingolipids by Microorganisms II. STRUCTURAL STUDIES ON TETRAACETYLPHYTOSPHINGOSINE FROM THE YEAST HANSENULA CIFERRII , 1960 .

[61]  S. Udaka,et al.  STUDIES ON THE AMINO ACID FERMENTATION , 1957 .